Pharmaceutical Errors
FDA’S DRUG APPROVAL PROCESS AND MEDWATCH PROGRAM
Every year, toxic side effects from prescription medications injury tens of thousands of Americans. Since 1997, over a dozen pharmaceutical medications were required to be removed from the marketplace by the U.S. Food and Drug Administration because of dangerous side effects including VIOXX ®, POSICOR ®, REDUX®, PONDIMIN® (FENFLURAMINE HYDROCHLORIDE), REZULIN®, SELDANE, PROPULSID®, BAYCOL® (CERIVASTATIN). [...]
CRESTOR® AND ANTI-CHOLESTEROL STATIN DRUGS
A small number of users of anti-cholesterol drugs called “statins” complain of a severe and debilitating side effect. The problems appear to be significantly more widespread in certain statin drugs that in others. Crestor® (Rosuvastatin calcium) is considered the most potent cholesterol-lowering statin drug on the market. Crestor is suspected to be the cause of [...]
CELEBREX®, BEXTRA® AND COX-2 INHIBITORS
Celebrex® (Celecoxib) is an anti-arthritis drug manufactured by Phiser. In December of 2004, FDA released the results of a post-marketing study of the drug, by advising U.S. physicians to “consider alternative therapy” to the prescription of Celebrex to patients. FDA also recommended that physicians prescribe Celebrex “only at the lowest possible dose.” The FDA stopped [...]